论文部分内容阅读
美国Roche公司最近报道,给患卡波济氏肉瘤的艾滋病病人使用α干扰素,结果表明干扰素能显著延长这些病人的存活时间。约1/3病人有效,平均存活时间为31个月,而无效者仅存活12个月。体外研究表
US Roche recently reported that alpha interferon was administered to AIDS patients with Kaposi’s sarcoma and the results showed that interferon significantly prolonged the survival of these patients. Approximately one-third of patients are effective, with an average survival of 31 months, while those who are ineffective survive for only 12 months. In vitro study table